SLA 0.00% $3.34 silk laser australia limited

no ropren sales until late 08, page-20

  1. 390 Posts.
    lightbulb Created with Sketch. 2
    My point is that I get a feeling there will be more stalling tactics.

    Still 4 months until the end off 2008.

    On 28 February 2008, Solagran announced to the ASX that Russian regulatory authorities
    were expected to release its new prescription pharmaceutical Ropren®for sale in the
    Russian market within 1 to 1.5 months.

    now looks like they are telling us the end of 2008.

    Holds no cred with me. Once bitten twice shy.

    I've heard it all before. Show us orders.
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.